Guidelines International Network | Guidelines International Network (GIN)

Therapie primärer Antikörpermangelerkrankungen. S3-LL (API)

MeSH Terms: Immunologic Deficiency Syndromes (C20.673)
Guideline Contact: Ina Kopp (imwi@awmf.org)
English Title Translation: Treatment of Patients with antibody deficiency syndromes
Date for Review: 01/12/2025
Publication Scope: management
Countries of Application: Germany
Guideline Publication Status: Under Review
Languages: German
Authors: AWMF (DE)
Publication Year: 2019

MeSH Terms: Cardiovascular Diseases (C14)
Guideline Contact: Ina Kopp (imwi@awmf.org)
English Title Translation: Therapy and aftercare of peripheral arterial occlusive disease
Keywords: periphere arterielle Verschlusskrankheit, pAVK, Schaufensterkrankheit, peripheral arterial disease, PAD, peripheral arterial occlusive disease
Date for Review: 17/09/2029
Publication Date: 18/09/2024
Publication Scope: assessment; management
Countries of Application: Germany
Guideline Publication Status: Published
Languages: German
Authors: AWMF (DE)
Publication Year: 2024

MeSH Terms: Adiposity (G03.180.134.500); Obesity (C18.654.726.500); Obesity (C23.888.144.699.500); Obesity (E01.370.600.115.100.160.120.699.500); Obesity (G07.100.100.160.120.699.500); Biochemical Phenomena (G02.111)
Guideline Contact: Ina Kopp (imwi@awmf.org)
English Title Translation: Therapy and prevention of obesity in childhood and adolescence
Date for Review: 31/07/2026
Publication Scope: management; prevention
Countries of Application: Germany
Guideline Publication Status: Under Review
Languages: German
Authors: AWMF (DE)
Publication Year: 2019

MeSH Terms: Language Disorders (C10.597.606.150.500); Language Disorders (C23.888.592.604.150.500)
Guideline Contact: Ina Kopp (imwi@awmf.org)
English Title Translation: therapy of language development disorders
Keywords: Sprachentwicklungsstörung, Sprachentwicklungsverzögerung, Late Talkers, Aussprachestörung, phonetische Störungen, phonologische Störung, lexikalisch-semantische Störung, morphologisch-syntaktische Störungen, pragmatisch-kommunikative Störungen, Sprachentwicklungsstörung bei Mehrsprachigkeit, Hörstörung, Mehrfachbehinderung, Autismus-Spektrum-Störung, selektiver Mutismus
Date for Review: 21/12/2027
Publication Date: 22/12/2022
Publication Scope: assessment; management
Countries of Application: Germany
Guideline Publication Status: Published
Languages: German
Authors: AWMF (DE)
Publication Year: 2022

MeSH Terms: carcinoma, non-small-cell lung, adenocarcinoma, bronchioloalveolar, lung, ErbB Receptors, HER2, HER-2, HER2-positive, HER2- overexpressing, HER2 gene amplification, Anaplastic Lymphoma Kinase, Receptor Protein-Tyrosine Kinases, Receptor, trkC, Proto-Oncogene Proteins, ROS1, ROS-1, Proto-Oncogene Proteins c-ret, Proto-Oncogene Proteins c-met, Phosphatidylinositol 3-Kinase, Genes, erbB-2, Quinazolines, Piperidines, Aminopyridines, Sulfones, Protein Kinase Inhibitors, Carbazoles, Lactams, Macrocyclic, Imidazoles, Pyrimidines, radiotherapy
Guideline Contact: Emily Vella; pebconc@mcmaster.ca
Keywords: carcinoma, non-small-cell lung, adenocarcinoma, bronchioloalveolar, lung, radiotherapy
Date for Review: In Program in Evidence-Based Care (PEBC), Ontario Health (Cancer Care Ontario), we have an annual review process for each guideline after it is completed. Guidelines are reviewed every fall after they are older than 1 year.
Publication Date: 2021-02-16
Date of Last Evidence Search: 2020-02-04
Methods Applied: Systematic review-based, Externally reviewed; Evidence quality assessment
Publication Scope: Guidelines; treatment
Countries of Application: Canada
Guideline Publication Status: Published
Languages: English
Authors: ASCO (US); PEBC (Program in evidenced-based care)
Publication Year: 2021